查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088639

獸醫腫瘤市場：按動物類型、治療方法、癌症類型、給藥途徑和最終用戶分類－2026-2032年全球市場預測

Veterinary Oncology Market by Animal Type, Treatment Mode, Cancer Type, Mode of Administration, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，獸醫腫瘤市場將成長至 47.4 億美元，複合年成長率為 14.47%。

主要市場統計數據
基準年 2025 18.4億美元
預計年份：2026年 20.9億美元
預測年份 2032 47.4億美元
複合年成長率 (%) 14.47%

隨著寵物壽命延長，飼主對癌症診斷和治療的要求也越來越高，獸醫腫瘤學已從一個小眾專科發展成為伴侶動物醫學的核心支柱。根據美國獸醫協會（AVMA）統計，大約四分之一的犬隻一生中會患有腫瘤，而10歲以上的犬隻中近一半會患上癌症，因此早期發現、分期和循證治療變得愈發重要。

獸醫腫瘤學的發展受到寵物「人性化」、專科醫院的擴張、CT、MRI、超音波、細胞學、組織病理學、免疫組織化學、流式細胞技術和分子檢測等技術的普及以及監管機構已通過核准的動物癌症療法的出現等因素的推動。在轉診網路、寵物保險和由認證腫瘤專家提供的服務能夠減輕寵物癌症治療的經濟負擔、確保治療的連續性並改善臨床決策的地區，獸醫腫瘤學的需求最為旺盛。

獸醫腫瘤學領域的變革性變化

獸醫腫瘤學領域正從傳統的化療轉向以患者為中心、多學科綜合治療，包括手術、放射線治療、腫瘤內科治療、疼痛管理、營養管理和安寧療護。細胞學、切片檢查、先進影像學、流式細胞技術和分子檢測等技術的應用，使得腫瘤分類、分期、預後評估和治療方案選擇更加精準，從而提高了診斷品質。

人工智慧在獸醫腫瘤學中的累積影響

人工智慧（AI）正開始影響獸醫腫瘤學的各個領域，包括影像審查、數位病理學、臨床文件、工作流程自動化和風險分層。人工智慧工具能夠幫助檢測X光、超音波影像影像、 電腦斷層掃描、組織切片、細胞學影像和電子健康記錄後續觀察。

全球獸醫腫瘤學的主要區域趨勢

北美，尤其是美國和加拿大，仍然是獸醫腫瘤學領域最成熟的地區，這得益於較高的寵物飼養率、完善的專科轉診網路、廣泛的寵物保險、先進的診斷技術以及獲得認證腫瘤專家的便捷途徑。其次，歐洲在歐盟範圍內建立了高標準的臨床體系，英國、德國、法國、義大利和西班牙均擁有成熟的腫瘤學服務，但保險報銷、藥物核准和轉診管道因國家而異。在俄羅斯，主要大都市地區憑藉著完善的寵物醫療保健基礎設施，腫瘤學的發展更為集中。

獸醫腫瘤需求的關鍵群體分析

在主要經濟領域，七國集團（G7）透過先進的專科護理、藥物和診斷技術的研發、學術研究、臨床培訓、寵物保險普及率的提高以及放射腫瘤學和先進診斷成像技術的普及，引領著獸醫腫瘤學領域的創新。歐盟在實施循證獸醫癌症護理和負責任的治療方面發揮著核心作用，提供統一的法律規範、跨境臨床標準、藥物安全監測要求以及健全的伴侶動物醫療保健基礎設施。

各國對伴侶動物癌症治療的深入了解

美國憑藉其龐大的專科醫院網路、經FDA批准的寵物癌症治療方案、先進的診斷技術、腫瘤專科住院醫師培訓計畫以及飼主對治療的堅定承諾，在獸醫腫瘤學領域處於領先地位。加拿大受益於類似的臨床標準和轉診體系，而墨西哥和巴西則透過都市區私立動物醫院、診斷實驗室以及不斷成長的伴侶動物醫療保健支出，擴大了腫瘤治療的覆蓋範圍。在歐洲，英國、德國、法國、義大利和西班牙擁有成熟的轉診網路、專業的腫瘤學專家團隊，並提供手術、影像、化療和安寧療護等服務。同時，俄羅斯的腫瘤治療發展正處於選擇性階段，主要集中在一些專科醫療服務和先進診斷技術較為集中的大城市。

為獸醫腫瘤學領導者提供的實用建議

行業領導者應優先考慮建立整合的腫瘤診療路徑，將初級保健獸醫、診斷實驗室、影像中心、外科醫生、腫瘤內科醫生、放射治療師、急診團隊和安寧療護專家聯繫起來。標準化的分期方案、腫瘤病例討論會、生存計劃、疼痛評估工具和飼主教育材料將有助於提高治療的一致性、依從性和信任度。

獸醫腫瘤學分析的調查方法

本執行摘要基於對已驗證的公共資源的系統性回顧，包括獸醫協會指南、監管資料庫、同行評審的獸醫腫瘤學文獻、動物保健行業資訊披露、臨床實踐標準、學術出版物以及當地寵物護理指標。檢驗由權威獸醫、監管機構、學術界和行業資訊來源提供的數據，例如疾病負擔證據、已批准的治療方案以及專業實踐資訊來源。

結論：獸醫腫瘤學的未來

隨著寵物癌症的診斷、治療和復健護理在全球範圍內變得越來越便捷，獸醫腫瘤學正朝著更數據主導和專業化的階段發展。這種需求的促進因素包括伴侶動物的老化、飼主對更先進護理的需求，以及在診斷、手術、放射線治療、全身性治療、免疫療法、標靶治療、疼痛管理和安寧療護等方面不斷提升的臨床能力。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 獸醫腫瘤市場：依動物類型分類

  • 狗
  • 馬
  • 異寵
    • 水生寵物
    • 鳥
    • 爬蟲類和兩棲類
  • 貓

第8章：獸醫腫瘤市場：依治療方法分類

  • 化療
    • 烷化劑
    • 抗代謝物
    • 細胞毒性藥物
    • 長春花生物鹼
  • 免疫療法
    • 癌症疫苗
    • 單株抗體
  • 放射治療
    • 近距離放射治療
    • 體外放射治療
  • 外科手術
  • 標靶治療

第9章：獸醫腫瘤市場：依癌症類型分類

  • 血管肉瘤
  • 淋巴瘤
  • 乳癌
  • 肥大細胞瘤
  • 骨癌

第10章：獸醫腫瘤市場：依給藥途徑分類

  • 靜脈注射（IV）
  • 口服
  • 外用

第11章 獸醫腫瘤市場：依最終用戶分類

  • 學術機構
  • 獸醫醫院和診所

第12章 獸醫腫瘤市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 獸醫腫瘤市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 獸醫腫瘤市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • AB Science SA
  • Anivive Lifesciences
  • Ardent Animal Health, LLC
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale SA
  • Covetrus, Inc.
  • Elanco Animal Health Incorporated
  • ELIAS Animal Health
  • Fidocure
  • IDEXX Laboratories, Inc.
  • Karyopharm Therapeutics Inc.
  • Leroy Biotech SAS
  • Merck KGaA,
  • Morphogenesis, Inc.
  • Nippon Zenyaku Kogyo Co., Ltd.
  • PetCure Oncology LLC
  • PharmAust Limited
  • Rhizen Pharmaceuticals AG
  • Torigen Pharmaceuticals Inc.
  • Varian Medical Systems, Inc.
  • Vetco Pharmaceuticals Inc.
  • VetDC, Inc.
  • Virbac SA
  • VolitionRx Limited
  • Zoetis Inc.
Product Code: MRR-A339DAEF9FFF

The Veterinary Oncology Market is projected to grow by USD 4.74 billion at a CAGR of 14.47% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.84 billion
Estimated Year [2026] USD 2.09 billion
Forecast Year [2032] USD 4.74 billion
CAGR (%) 14.47%

Veterinary oncology has moved from a niche specialty into a core pillar of companion animal health care as pets live longer and owners pursue advanced cancer diagnostics and treatment. The American Veterinary Medical Association reports that approximately one in four dogs will develop neoplasia during life, and nearly half of dogs over age ten develop cancer, making early detection, staging, and evidence-based treatment increasingly important.

Growth in veterinary oncology is supported by pet humanization, expanding specialty hospitals, broader access to CT, MRI, ultrasound, cytology, histopathology, immunohistochemistry, flow cytometry, and molecular testing, and the availability of regulator-approved animal cancer therapies. Demand is strongest where referral networks, pet insurance, and board-certified oncology services improve affordability, continuity of care, and clinical decision-making for pet cancer treatment.

Transformative Shifts in the Veterinary Oncology Landscape

The veterinary oncology landscape is shifting from generalized chemotherapy toward multimodal, patient-specific care that combines surgery, radiation therapy, medical oncology, pain management, nutrition, and palliative support. Diagnostic quality is rising as cytology, biopsy, advanced imaging, flow cytometry, immunophenotyping, and molecular assays enable more accurate tumor classification, staging, prognosis, and treatment selection.

A second transformation is commercial and operational. Specialty hospitals are expanding referral capacity, general practitioners are using teleconsultation to triage complex cases, and owners increasingly evaluate treatment based on survival benefit, quality of life, adverse-event management, and transparent cost. These shifts favor providers that can integrate diagnostics, referral pathways, clinical protocols, clinical trial access, and compassionate communication.

Cumulative Impact of Artificial Intelligence on Veterinary Oncology

Artificial intelligence is beginning to affect veterinary oncology across imaging review, digital pathology, clinical documentation, workflow automation, and risk stratification. AI-enabled tools can help detect patterns in radiographs, ultrasound images, CT scans, histology slides, cytology images, and electronic medical records, supporting faster triage and more consistent follow-up for suspected pet cancer cases.

The cumulative impact is operational rather than fully autonomous: AI can reduce diagnostic delays, improve case prioritization, standardize reporting, support clinical decision support, and strengthen real-world evidence generation. However, adoption depends on veterinary-specific validation, explainable models, clinician oversight, data privacy, high-quality annotated datasets, and integration with laboratory information systems and hospital workflows.

Key Regional Insights Across Global Veterinary Oncology

North America remains the most mature regional environment for veterinary oncology, supported by high companion animal ownership, specialty referral networks, pet insurance adoption, advanced diagnostics, and access to board-certified oncologists, particularly in the United States and Canada. Europe follows with strong clinical standards across the European Union and established oncology services in the United Kingdom, Germany, France, Italy, and Spain, although reimbursement, medicine authorization, and referral access vary by country. Russia shows more concentrated development in major urban centers where advanced companion animal care infrastructure is available.

Asia-Pacific is expanding as urban pet ownership, premium veterinary clinics, and advanced diagnostics grow in China, Japan, Australia, South Korea, and India. Japan and Australia have well-established companion animal care systems, while China and India are building specialist capacity alongside rapid growth in urban veterinary services. Latin America is led by Brazil and Mexico, where companion animal populations, private veterinary investment, and diagnostic access are increasing. The Middle East, particularly GCC markets, is developing premium pet care infrastructure supported by high-income urban demand, while Africa remains earlier-stage, with growth concentrated in urban centers, veterinary schools, and private referral practices where pathology, imaging, and specialty surgery are accessible.

Key Group Insights for Veterinary Oncology Demand

Within major economic groups, the G7 anchors veterinary oncology innovation through advanced specialty care, pharmaceutical and diagnostic development, academic research, clinical training, pet insurance penetration, and stronger access to radiation oncology and advanced imaging. The European Union contributes harmonized regulatory oversight, cross-border clinical standards, pharmacovigilance requirements, and strong companion animal health infrastructure, making it central to evidence-based veterinary cancer care and responsible therapeutic adoption.

BRICS markets offer scale and long-term demand potential, especially in Brazil, China, and India, where pet populations, urban clinics, and private veterinary services are expanding, while specialist density remains uneven. ASEAN is gaining relevance through urbanization and premium pet care growth in markets such as Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines, with referral oncology emerging first in higher-income metropolitan areas. GCC countries are investing in high-end veterinary services, modern clinics, and companion animal diagnostics, while NATO countries collectively overlap with many of the world's strongest biomedical research, animal health, military working dog medicine, and specialty hospital ecosystems.

Key Country Insights in Companion Animal Cancer Care

The United States leads veterinary oncology through deep specialty hospital coverage, FDA-approved pet cancer therapies, advanced diagnostics, oncology residency training, and strong owner willingness to treat. Canada benefits from similar clinical standards and referral pathways, while Mexico and Brazil are expanding oncology access through urban private practices, diagnostic laboratories, and growing companion animal care spending. In Europe, the United Kingdom, Germany, France, Italy, and Spain support mature referral networks, professional oncology expertise, and access to surgery, imaging, chemotherapy, and palliative care, while Russia shows selective development in major cities where specialty services and advanced diagnostics are concentrated.

China and India represent high-potential veterinary oncology environments driven by rising pet ownership, urban clinics, premium pet care, and increasing diagnostic investment, though specialist availability and access to advanced therapies remain uneven. Japan has a sophisticated small animal veterinary sector with strong demand for minimally invasive diagnostics and quality-of-life-focused care. Australia benefits from established referral hospitals, veterinary schools, and advanced imaging access, while South Korea is supported by high urban pet ownership, modern clinics, and demand for specialized companion animal medicine. Across all countries, adoption is highest where general practitioners, diagnostic laboratories, surgeons, radiation centers, medical oncologists, and palliative care teams are connected through reliable referral pathways.

Actionable Recommendations for Veterinary Oncology Leaders

Industry leaders should prioritize integrated oncology pathways that connect primary veterinarians, diagnostic laboratories, imaging centers, surgeons, medical oncologists, radiation therapy providers, emergency teams, and palliative care specialists. Standardized staging protocols, tumor boards, survivorship plans, pain assessment tools, and owner education materials can improve treatment consistency, adherence, and trust.

Commercial strategies should focus on affordability, evidence, and access. Providers can expand through teleoncology, regional referral hubs, AI-assisted workflow tools, clinical trial partnerships, remote follow-up, and real-world outcomes registries. Manufacturers and service providers should invest in veterinary-specific indications, companion diagnostics, validated biomarkers, safety monitoring, pharmacovigilance, and post-authorization evidence to demonstrate measurable value for pets, owners, and clinicians.

Research Methodology for Veterinary Oncology Analysis

This executive summary is based on a structured review of verified public sources, including veterinary association guidance, regulatory databases, peer-reviewed veterinary oncology literature, animal health industry disclosures, clinical practice standards, academic publications, and regional pet care indicators. Emphasis is placed on data that can be corroborated through recognized veterinary, regulatory, academic, and industry sources, including disease burden evidence, approved therapeutic references, and professional specialty care standards.

The analysis applies market triangulation by comparing disease burden, pet ownership trends, specialty care availability, diagnostic adoption, regulatory approvals, clinical infrastructure, and regional veterinary service maturity. Qualitative insights are synthesized across demand drivers, technology adoption, competitive positioning, treatment access, and care delivery models to support decision-making in the veterinary oncology landscape without relying on market sizing, share estimates, or forecasts.

Conclusion: The Future of Veterinary Oncology

Veterinary oncology is entering a more data-driven and specialized phase as pet cancer diagnosis, treatment, and survivorship care become more accessible worldwide. Demand is reinforced by aging companion animals, owner willingness to pursue advanced care, and expanding clinical capabilities in diagnostics, surgery, radiation therapy, systemic therapy, immunotherapy, targeted treatment, pain control, and palliative medicine.

The next stage of development will depend on validated AI, stronger referral ecosystems, affordable treatment pathways, improved specialist training, and regionally appropriate service models. Organizations that combine clinical evidence, operational efficiency, compassionate communication, ethical care planning, and measurable outcomes will be best positioned in the global veterinary oncology landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Veterinary Oncology Market, by Animal Type

  • 7.1. Canine
  • 7.2. Equine
  • 7.3. Exotic Pets
    • 7.3.1. Aquatic Pets
    • 7.3.2. Birds
    • 7.3.3. Reptiles & Amphibians
  • 7.4. Feline

8. Veterinary Oncology Market, by Treatment Mode

  • 8.1. Chemotherapy
    • 8.1.1. Alkylating Agents
    • 8.1.2. Antimetabolites
    • 8.1.3. Cytotoxic Agents
    • 8.1.4. Vinca Alkaloids
  • 8.2. Immunotherapy
    • 8.2.1. Cancer Vaccines
    • 8.2.2. Monoclonal Antibodies
  • 8.3. Radiotherapy
    • 8.3.1. Brachytherapy
    • 8.3.2. External Beam Radiotherapy
  • 8.4. Surgery
  • 8.5. Targeted Therapy

9. Veterinary Oncology Market, by Cancer Type

  • 9.1. Hemangiosarcoma
  • 9.2. Lymphoma
  • 9.3. Mammary Carcinoma
  • 9.4. Mast Cell Tumors
  • 9.5. Osteosarcoma

10. Veterinary Oncology Market, by Mode of Administration

  • 10.1. Intravenous (IV)
  • 10.2. Oral
  • 10.3. Topical

11. Veterinary Oncology Market, by End User

  • 11.1. Academic Institutions
  • 11.2. Veterinary Hospitals & Clinics

12. Veterinary Oncology Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Veterinary Oncology Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Veterinary Oncology Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. AB Science SA
  • 16.2. Anivive Lifesciences
  • 16.3. Ardent Animal Health, LLC
  • 16.4. Boehringer Ingelheim International GmbH
  • 16.5. Ceva Sante Animale S.A.
  • 16.6. Covetrus, Inc.
  • 16.7. Elanco Animal Health Incorporated
  • 16.8. ELIAS Animal Health
  • 16.9. Fidocure
  • 16.10. IDEXX Laboratories, Inc.
  • 16.11. Karyopharm Therapeutics Inc.
  • 16.12. Leroy Biotech S.A.S.
  • 16.13. Merck KGaA,
  • 16.14. Morphogenesis, Inc.
  • 16.15. Nippon Zenyaku Kogyo Co., Ltd.
  • 16.16. PetCure Oncology LLC
  • 16.17. PharmAust Limited
  • 16.18. Rhizen Pharmaceuticals AG
  • 16.19. Torigen Pharmaceuticals Inc.
  • 16.20. Varian Medical Systems, Inc.
  • 16.21. Vetco Pharmaceuticals Inc.
  • 16.22. VetDC, Inc.
  • 16.23. Virbac SA
  • 16.24. VolitionRx Limited
  • 16.25. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY ONCOLOGY MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL VETERINARY ONCOLOGY MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL VETERINARY ONCOLOGY MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL VETERINARY ONCOLOGY MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL VETERINARY ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CANINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CANINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CANINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL EQUINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL EQUINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL EQUINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL EXOTIC PETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL EXOTIC PETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL EXOTIC PETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AQUATIC PETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AQUATIC PETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AQUATIC PETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIRDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIRDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIRDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL REPTILES & AMPHIBIANS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL REPTILES & AMPHIBIANS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL REPTILES & AMPHIBIANS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FELINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FELINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FELINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CHEMOTHERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CHEMOTHERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CHEMOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ALKYLATING AGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ALKYLATING AGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ALKYLATING AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANTIMETABOLITES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANTIMETABOLITES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANTIMETABOLITES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CYTOTOXIC AGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CYTOTOXIC AGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CYTOTOXIC AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VINCA ALKALOIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VINCA ALKALOIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VINCA ALKALOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL IMMUNOTHERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL IMMUNOTHERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CANCER VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CANCER VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CANCER VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RADIOTHERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RADIOTHERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BRACHYTHERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BRACHYTHERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL TARGETED THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL TARGETED THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL TARGETED THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HEMANGIOSARCOMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HEMANGIOSARCOMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HEMANGIOSARCOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL LYMPHOMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL LYMPHOMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL LYMPHOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MAMMARY CARCINOMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MAMMARY CARCINOMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MAMMARY CARCINOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MAST CELL TUMORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MAST CELL TUMORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MAST CELL TUMORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL OSTEOSARCOMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL OSTEOSARCOMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL OSTEOSARCOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRAVENOUS (IV) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL INTRAVENOUS (IV) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRAVENOUS (IV) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. GCC VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. GCC VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. GCC VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 172. GCC VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 173. GCC VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 174. GCC VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 175. GCC VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 176. GCC VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. GCC VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 178. GCC VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. G7 VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. G7 VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. G7 VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 202. G7 VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 203. G7 VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 204. G7 VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 205. G7 VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 206. G7 VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. G7 VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 208. G7 VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. NATO VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 210. NATO VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. NATO VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 212. NATO VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 213. NATO VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 214. NATO VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 215. NATO VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 216. NATO VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. NATO VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 218. NATO VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. CANADA VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 231. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 233. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 234. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 235. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 236. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 237. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 239. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. MEXICO VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 241. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 243. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 244. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 245. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 246. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 247. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 249. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 251. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 253. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 254. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 255. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 256. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 257. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 259. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 270. GERMANY VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 271. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 273. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 274. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 275. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 276. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 277. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 279. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. FRANCE VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 281. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 283. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 284. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 285. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 286. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 287. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 289. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 290. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 291. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 293. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 294. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 295. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 296. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 297. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 299. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. ITALY VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 301. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 303. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 304. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 305. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 306. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 307. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 309. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 310. SPAIN VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 311. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 313. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 314. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 315. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 316. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 317. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 318. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 319. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 320. CHINA VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 321. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 322. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 323. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 324. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 325. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 326. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 327. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 329. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 330. INDIA VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 331. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 333. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 334. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 335. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 336. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 337. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 338. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 339. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 340. JAPAN VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 341. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 342. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 343. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 344. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 345. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 346. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 347. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 348. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 349. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 350. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 351. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 352. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 353. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 354. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 355. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 356. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 357. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 358. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 359. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 360. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 361. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 362. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY EXOTIC PETS, 2018-2032 (USD MILLION)
  • TABLE 363. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 364. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 365. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 366. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 367. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
  • TABLE 368. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY